Jose Teixeira is a Professor in the Department of Obstetrics, Gynecology and Reproductive Biology. His research focuses on the reproductive tract and gonadal development.
Dr. Teixeira received his Ph.D. from the University of Massachusetts Medical School. He completed his post-doctoral training at Massachusetts General Hospital and Harvard Medical School. Prior to joining MSU, Dr. Teixeira held faculty positions at MGH and Harvard; he was also an Investigator in the Vincent Center for Reproductive Biology, Principal Investigator in the Harvard Stem Cell Institute, and an affiliate member at MGH Cancer Center and the Dana Farber Harvard Cancer Center.
Dr. Teixeira’s lab has four main research projects: (1) dissecting the signaling mechanisms common to Wnt/β-catenin and PI3K in the gonads and uterus and the pathophysiological consequences when they are dysregulated, a potential cause of uterine fibroid development and gonadal and endometrial cancers; (2) identification and molecular characterization of the uterine stem/progenitor cells and the functional effects of endocrine disruption on their behavior during uterine development and during normal uterine functions; (3) cryopreservation and maturation of primary follicles in vitro for somatic cell nuclear transfer applications and as a mechanism to rescue the fertility of patients who are having their ovaries removed or destroyed by gonadotoxic therapies; and (4) investigating the therapeutic use of MIS in ovarian cancer and as an inhibitor of ovarian follicle development.